We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 3 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 2 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2025. 08. 04. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 06. 17. | Texas Capital Securities | — | Initiate coverage | — → Buy | — | Texas Capital Securities: Buy |
| 2025. 05. 03. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
| 2025. 04. 30. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2024. 09. 17. | Zelman & Assoc | — | Downgrade | Neutral → Underperform | — | Zelman & Assoc: Neutral → Underperform |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.